Year None202420232022202120202019201820172016 Date Latest Press Release August 5, 2019 Eiger BioPharmaceuticals to Participate in Investor Conferences in August June 17, 2019 Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide for Treatment of Post-Bariatric Hypoglycemia (PBH) June 10, 2019 Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs June 5, 2019 Eiger Appoints Jeysen Yogaratnam, MB.BCh, BAO, MRCSEd, PhD, MBA, Vice President of Global HDV Clinical Development May 30, 2019 Eiger BioPharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference May 17, 2019 Eiger BioPharmaceuticals Announces Transition of Chief Operating Officer and Executive Medical Officer May 9, 2019 Eiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update April 30, 2019 Eiger to Present at ChinaBio® Partnering Forum 2019 April 17, 2019 Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock April 17, 2019 Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock Pagination First page « first Previous page ‹ previous … Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Page 15 Page 16 … Next page next › Last page last »